最新文章：伊维菌素和芬苯达唑治疗案例——一位65岁的加拿大男子患有扁桃体T细胞间变性淋巴瘤，三个月后报告治疗情况从萨尔瓦多回家的路上……还有比这更好的时机来写篇推荐信吗？ 😃故事：一名65岁的加拿大男子患有扁桃体T细胞间变性淋巴瘤2025年7月初，他开始：伊维菌素 1mg/kg/天芬苯达唑 1000 毫克/天化疗结果：第三次化疗结束后（CT 报告在此），他的淋巴瘤病灶已经消退。伊维菌素和芬苯达唑是化疗增敏剂，可以增强化疗对癌细胞的杀伤作用，我们在许多淋巴瘤病例中都看到了非常显著的疗效。我拥有全球最大的伊维菌素抗癌患者群体，超过7200名癌症患者。NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 65 year old Canadian Man with T-cell Anaplastic Lymphoma of the tonsils reports after 3 monthsOn my way back home from El Salvador...what better time to post a testimonial? 😃STORY:65 year old Canadian Man with T-cell Anaplastic Lymphoma of the tonsilsIn early July 2025 he started:Ivermectin 1mg/kg/dayFenbendazole 1000mg/dayChemotherapyResults:After the end of his 3rd chemotherapy (the CT Report here), his lymphoma sites had resolved.Ivermectin and Fenbendazole are chemosensitizers that enhance cancer cell killing by chemotherapy and we see very dramatic responses in many Lymphoma cases.I have the world's largest Ivermectin Cancer clientele, 7200+ Cancer patients
